NRx Pharmaceuticals (Nasdaq:NRXP) Reports First Quarter 2026 Financial Results and Provides Corporate Update
Go back to NRx Pharmaceuticals (Nasdaq:NRXP) Reports First Quarter 2026 Financial Results and Provides Corporate Update| (NASDAQ: NRXP) | Delayed: 3.90 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.90 | 52 Week High | $ | |||
| Open | $3.90 | 52 Week Low | $ | |||
| Day High | $3.90 | P/E | N/A | |||
| Day Low | $3.90 | EPS | $ | |||
| Volume | 4,317 | |||||

